文献速递青光眼白内障与屈光手术

经内路房水通路重建术联合微切口白内障手术治疗原发性开角型青光眼合并白内障的初步疗效:一年结果

[Preliminary efficacy of ab interno canaloplasty combined with micro-incision cataract surgery in primary open angle glaucoma combined with cataract: one-year results].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2022-01-01

前瞻性病例系列研究纳入42例(68只眼)原发性开角型青光眼合并白内障患者,行经内路房水通路重建术联合微切口超声乳化白内障吸除及人工晶状体植入术。术后1、3、6、12个月眼压较术前用药控制眼压显著下降,抗青光眼药物使用数量显著减少,12个月完全成功率80.88%、条件成功率89.71%,无严重并发症。

要点

  • 术后12个月眼压从术前用药控制的(18.25±2.65)mmHg降至(14.84±2.73)mmHg,差异有统计学意义。
  • 抗青光眼药物使用数量中位数从术前2.5种降至术后12个月0种,显著减少。
  • 术后12个月完全成功率80.88%(55/68),条件成功率89.71%(61/68),无严重并发症。

核心结论

  • 经内路房水通路重建术联合微切口白内障手术治疗原发性开角型青光眼合并白内障在中国人群中短期疗效和安全性可靠。

研究设计与样本

  • 前瞻性病例系列研究,纳入2018年6月至2019年10月浙江大学医学院附属第二医院眼科中心确诊为原发性开角型青光眼合并白内障并行联合手术的患者42例(68只眼),完成12个月随访。

主要发现

  • 术后1个月眼压(14.31±3.25)mmHg、3个月(14.00±3.09)mmHg、6个月(14.58±2.93)mmHg、12个月(14.84±2.73)mmHg,均较术前用药控制眼压(18.25±2.65)mmHg显著下降(P<0.05)。
  • 抗青光眼药物使用数量中位数术前2.5(2,3)种,术后1个月降至0(0,1)种,术后3、6、12个月均为0(0,0)种,术后较术前显著减少(P<0.05)。
  • 术后12个月完全成功率80.88%(55/68),条件成功率89.71%(61/68)。
  • 术后12个月视野缺损及视神经光学相干断层扫描较术前总体无明显进展。
  • 术后早期前房出血26只眼(38.24%),一过性眼压升高23只眼(33.82%),均无严重病例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the preliminary efficacy and safety of ab interno canaloplasty (ABiC) combined with micro-incision cataract surgery for treating primary open angle glaucoma (POAG) combined with cataract. Methods: Prospective case series study. Patients diagnosed with POAG and concurrent cataract were enrolled to receive ABiC combined with micro-incision phacoemulsification and intraocular lens implantation in the Eye Center of the Second Affiliated Hospital of Zhejiang University School of Medicine from June 2018 to October 2019. Intraocular pressure (IOP), use of hypotensive medications, visual acuity, visual field, and optic nerve at baseline as well as at 1 day, 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively were assessed. Subgroup analyses were further performed to evaluate these data between controlled and uncontrolled POAG, as well as among mild, moderate, and advanced POAG. Success rate and complications were analyzed. Results: A total of 68 eyes in 42 patients completed a follow-up of 12 months. Compared to the baseline IOP under medical control [(18.25±2.65) mmHg (1 mmHg=0.133 kPa)], the mean postoperative IOP at 1 month [(14.31±3.25) mmHg], 3 months [(14.00±3.09) mmHg], 6 months[ (14.58±2.93) mmHg], and 12 months[ (14.84±2.73) mmHg] was all significantly reduced (P<0.05). The median (upper quadrant, lower quadrant) of the hypotensive medication number was 2.5 (2, 3) at baseline, which was significantly reduced to 0 (0, 1) at 1 month, and 0 (0, 0) at 3, 6, and 12 months (P<0.05). The complete success rate and qualified success rate at 12 months were 80.88%(55/68) and 89.71%(61/68), respectively. No deterioration in the visual field or optical coherence tomography scan of the optic nerve was observed at 12 months compared to the baseline status. Hyphema (26 eyes, 38.24%) and transient IOP spike (23 eyes, 33.82%) were the most common complications, but no severe case was present. Conclusion: ABiC combined with micro-incision cataract surgery is considerably effective and safe in the treatment of POAG combined with cataract in the Chinese population. 目的: 探讨经内路房水通路重建术(ABiC)联合微切口超声乳化白内障吸除术治疗原发性开角型青光眼(POAG)合并白内障的短期疗效和安全性。 方法: 前瞻性病例系列研究。选取2018年6月至2019年10月于浙江大学医学院附属第二医院眼科中心确诊为POAG(早、中、晚期)合并白内障,拟行ABiC联合微切口超声乳化白内障吸除联合人工晶状体植入术患者,按术前眼压控制情况、视野平均缺损、小梁网色素分级评分进行分组,记录术前和术后1 d、1周、1个月、3个月、6个月、12个月各组术眼的眼压、视野、视神经情况及抗青光眼药物使用数量,统计手术成功率、术中及术后并发症情况。采用χ2检验、t检验、方差分析、最小显著性差异法、秩和检验进行统计学分析。 结果: 42例患者(68只眼)完成为期12个月的术后随访。与术前使用抗青光眼药物控制的眼压[(18.25±2.65)mmHg(1 mmHg=0.133 kPa)]相比,术后1个月[(14.31±3.25)mmHg]、3个月[(14.00±3.09)mmHg]、6个月[(14.58±2.93)mmHg]、12个月[(14.84±2.73)mmHg]眼压明显下降,差异具有统计学意义(P<0.05)。抗青光眼药物使用数量中位数术前为2.5(2,3)种,术后1个月为0(0,1)种,术后3、6、12个月均为0(0,0)种,术后较术前显著减少(P<0.05)。术后12个月手术完全成功率和条件成功率分别为80.88%(55/68)和89.71%(61/68)。术后12个月术眼视野缺损及视神经损伤情况总体无明显进展。主要手术并发症包括术后早期前房出血(26只眼,38.24%)及一过性眼压升高(23只眼,33.82%),均对预后无不良影响。 结论: ABiC联合微切口超声乳化白内障吸除术治疗POAG合并白内障短期疗效和安全性可靠。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Lyu DN, Lu B, Zhang LF, et al. [Preliminary efficacy of ab interno canaloplasty combined with micro-incision cataract surgery in primary open angle glaucoma combined with cataract: one-year results]. Zhonghua Yan Ke Za Zhi. 2022. PMID: 35391515. doi:10.3760/cma.j.cn112142-20211028-00510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。